Clinical Activity, Tolerability, and Long-Term Follow-Up of Durvalumab in Patients With Advanced NSCLC

Overview of attention for article published in Journal of Thoracic Oncology, June 2019

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (85th percentile)
Good Attention Score compared to outputs of the same age and source (66th percentile)

Mentioned by

news: 1 news outlet
twitter: 1 X user

reddit: 1 Redditor
guideline: 1 clinical guideline source

Readers on

mendeley: 90 Mendeley

So far, Altmetric has seen 1 X post from an account with 257 followers.

Clinical Activity, Tolerability, and Long-term Follow-up of Durvalumab in Patients With Advanced NSCLC. https://t.co/fJnbrxlfzf

This page shows the most recent X posts that mention this research output. Click here to find out how to access more activity.

Login to access the Sentiment Analysis related to this output.